Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Scholar Rock Holdings Corporation

SRRK
44,78
2,69 (6,39%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/12/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
26/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
13/11/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00BWScholar Rock Reports Third Quarter 2024 Financial Results..
04/11/202414:00BWScholar Rock Announces New Preclinical Data for SRK-439..
01/11/202413:00BWScholar Rock to Host Conference Call to Discuss Third..
31/10/202421:00BWScholar Rock to Participate in Upcoming Investor Conferences
31/10/202413:00BWScholar Rock to Present New Clinical and Biomarker Data from..
22/10/202414:00BWScholar Rock Announces Closing of Full Exercise of Option to..
18/10/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
10/10/202412:05EDGAR2Form 8-K - Current report
09/10/202422:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/10/202405:08BWScholar Rock Announces Pricing of Upsized $300 Million..
08/10/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202422:09BWScholar Rock Announces Proposed Public Offering of Common..
07/10/202414:00EDGAR2Form 8-K - Current report
07/10/202413:00BWScholar Rock Reports Apitegromab Meets Primary Endpoint in..
19/9/202414:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
10/9/202414:00BWScholar Rock Completes Enrollment in Phase 2 EMBRAZE..
04/9/202414:00BWScholar Rock Appoints Beth Shafer, Ph.D., to Chief Business..
29/8/202414:00BWScholar Rock to Participate in Upcoming Investor Conferences
19/8/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
08/8/202413:20EDGAR2Form 8-K - Current report
08/8/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00BWScholar Rock Reports Second Quarter 2024 Financial Results..
30/7/202401:27EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
23/7/202414:00BWScholar Rock to Host Conference Call to Discuss Second..
12/7/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
24/6/202413:00BWScholar Rock Announces New SRK-439 Preclinical Data Showing..
18/6/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
03/6/202422:25EDGAR2Form 8-K - Current report
03/6/202422:00BWScholar Rock Presents New Data from SRK-181 Phase 1 DRAGON..
28/5/202414:00BWScholar Rock to Present New Data from SRK-181 Phase 1 DRAGON..
22/5/202414:30EDGAR2Form 8-K - Current report
22/5/202413:00BWScholar Rock Announces Initiation of Phase 2 EMBRAZE Trial..
20/5/202414:00BWScholar Rock to Participate in Upcoming Investor Conferences
17/5/202422:15BWScholar Rock Reports New Employee Inducement Grants Under..
14/5/202414:00BWScholar Rock to Host Investor Day on May 22, 2024
14/5/202413:15EDGAR2Form 8-K - Current report
07/5/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:20EDGAR2Form 8-K - Current report
07/5/202413:00BWScholar Rock Reports First Quarter 2024 Financial Results..
Apertura: 41,77 Min: 41,535 Max: 45,8399
Chiusura: 42,09

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network